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Three possible mechanisms have been proposed to explaindevelopment and main-
tenance ofT cell tolerance to self antigens : the inactivation of self-reactive lympho-
cytes (clonal anergy), their chronicsuppression (clonal suppression), and their elimi-
nation (clonal deletion) (1, 2) . Experimental attempts to prove these three possibilities
have been severely limited because of the technical difficulties (2) . A more direct
approach to assess the cellular basis of tolerance induction, however, isnow available
by using the fact that the usage ofa certainTCR Vo domain is strongly correlated
with the reactivity to specific antigens (3-5) . By exploiting such correlations, it has
been demonstrated that self-tolerance to the products encoded by the Mls-1a allele
(4, 5) or the Mls-2a allele (6, 7) is mediated via the clonal deletion of the self-reactive
T cell clones .
As to tolerance induction to allogeneic antigens, many attempts have been ex-
perimentally made . Those include neonatally induced tolerance (8), irradiation-
inducedtolerance (9-11), and antilymphocyte serum-induced tolerance (12, 13) . Re-
cently, MacDonald et al . (14) have indicated that neonatally induced tolerance to
Mls-la-encoded antigens was likewise accompanied by the intrathymic elimination
of V06-bearing cells, which are capable of recognizing Mls-1a-encoded antigens
bound toMHC class II molecules, thus supporting the clonal deletion model. On
the other hand, Qin et al . (15) have raised the possibility that tolerance to allograft
induced by combining bone marrow transplantation (BMT)1 together with ad-
ministration ofCD4 andCD8mAb in adult mice is, at least in part, due to clonal
anergy rather than deletion . Thus, the underlying mechanisms in the development
and maintenance of the donor-specific transplantation tolerance still remain con-
troversial .
We have previously reported a method of allo-tolerance induction in adult mice
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that comprises intravenous injection of 108 allogeneic spleen cells followed, usually
2 d later, by administration of 200 mg/kg of cyclophosphamide (CP) by the in-
traperitoneal route. Using this method, we have readily established a minimal de-
gree of mixed chimerism associated with a-long-lasting skin allograft tolerance in
a variety ofH-2 haplotype-identical strain combinations in mice (16). Possible mech-
anisms of this tolerance induction have been considered to be destruction of antigen-
stimulated and then proliferating reactive cells (17-19) followed by establishment of
a minimal degree of mixed chimerism (16, 20).
In the present article, in order to address this issue more directly, we have inves-
tigated the cellular basis of the transplantation tolerance in a model system of C3H
(Mls-1b) mice rendered CP-induced tolerant to AKR (Mls-1a) skin allografts by as-
sessing T cells bearing V06 reactive to Mls-la-encoded antigens. Our results indi-
cated that both destruction of donor antigen-stimulated T cells in the periphery
and intrathymic clonal elimination of donor-reactive T cells were essential mecha-
nisms of GP-induced tolerance.
Materials and Methods
Animals.
￿
Inbred mice ofC3H/HdSIc (C3H; H-2k, Mls-16), AKR/JSea (AKR; H-2k, Mls-
la), B10.BR SgSnSlc (B10.BR; H-2k, Mls-1 6), BALB/cCrSlc (BALB; H-2d, Mls-1 6),
DBA/2CrSlc (DBA; H-2d, Mls-l a), and Bl0.D2 nSnSlc (B10.D2; H-2d, Mls-1 6) strains were
obtained from the Seiwa Experimental Animal Center (Nakatsu, Oita, Japan) and theJapan
SLC Inc. (Hamamatsu, Shizuoka, Japan). Female mice, 8-10 wk old, were used.
CellPreparation.
￿
Mice were killed by decapitation. The thymus, spleen, and lymph nodes
(axillary, inguinal, and mesenteric) were collected and kept on ice in HBSS. They were dis-
rupted in the medium by pressing their fragments between two glass slides. Cell suspensions
were filtered through cotton gauze and washed three times in HBSS. Viable nucleated cells
were counted. Viability of the cells was evaluated using trypan blue dye exclusion in a stan-
dard way.
In some experiments (Table III), cortisone-resistant thymocytes were obtained 48 h after
a single intraperitoneal injection of 4 mg of hydrocortisone acetate (see reference 21).
Drug and Tolerance Induction.
￿
CP (Endoxan, Shionogi, Tokyo, Japan) in PBS (20 mg/ml)
was injected intraperitoneally at a dose of 200 mg/kg. The day of CP injection is called day
0. Recipient mice were primed (on day -2) intravenously with 108 spleen cellsofdonor mice
in 0.5 ml of HBSS and were given 200 mg/kg CP intraperitoneally 2 d later (on day 0).
Skin Grafting.
￿
Using the procedure we have reported previously (22), skin grafting was
carried out usually 2 wk after CP treatment (on day 14). Graft beds, measuring 1 x 1 cm,
were prepared on the right lateral thoracic wall. The panniculus carnosus was kept intact
in the graft beds. Full-thickness square grafts, 1 x 1 cm, were sutured to the graft beds by
eight interrupted sutures and were covered with protective tape. The first inspection of skin
grafts was done 7 d aftergrafting, followed by daily inspections for 3 wk and weekly inspec-
tionsthereafter. In the tolerant state, luxurious hair growth was demonstrated with the growth
ofhair ofa different color from the normal hairofthe recipient strain. Graftswere considered
as rejected when the grafts formed dry scabs or when all of the normal epithelium was lost.
Double-blinded observation was not performed. Graft survival was expressed in days as mean
survival time (MST) t SD.
Flow Microfluorometry.
￿
The direct immunofluorescent method using FITC-conjugated anti-
Thy-1.2, anti-Lyt-1 (Becton Dickinson & Co., Mountain View, CA), antiThy-1.1, and anti-
Lyt-1.1 (Meiji, Tokyo, Japan) mAbs was used to stain lymph node cells and thymus cells for
the assay of chimerism. Undiluted culture supernatant of the rat hybridoma, 44-22-1, was
used as a mAb that recognizes all TCRs using Vsb gene segments (4) in order to stainlymph
node cells and thymus cells followed by FITC-conjugated goat anti-rat IgG (Tago Inc., Burlin-
game, CA). mAb KJ16-133, which recognizes TCRs usingproducts of the Vs8 gene family
(VS8.v8.2) (23), was also used. Fluorescence-positive cells were measured mainly by meansETO ET AL.
￿
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of a FRCS 440 flow cytometer (Becton Dickinson & Co.), and in some experiments (Table
IV and Fig. 5) by a FACScan (Becton Dickinson & Co.). The scatter was used to exclude
dead cells, and fluorescence histograms (representing 104-105 viable cells) were accumulated
on a logarithmic scale. Data were presented as percent positive cells after subtracting the
number of cells stained with the fluorescent conjugate alone.
In some experiments, a cell suspension was incubated with both FITC-conjugated mAb
and phycoerythrin (PE)-conjugated mAb for two-color flow cytometry. PE-conjugated anti-
CD4 mAb and anti-CD8 mAb were purchased from Becton Dickinson & Co. All data were
displayed on a log scale of increasing green and red fluorescence intensity. To obtain per-
centage of a T cell subpopulation, a total count was integrated in a selected area ofthe con-
tour plots.
MixedLymphocyte Reaction (MLR).
￿
Spleen cells were used as both responders and stimu-
lators in MLR. Spleen cells were washed and reconstituted in RPMI 1640 medium (Gibco
Laboratories, Grand Island, NY), which was supplemented with 10% Nu-serum (Collabora-
tive Research, Lexington, MA), 5 x 10-5 M 2-ME, and antibiotics (100 U/ml penicillin and
100 pg/ml streptomycin). The responder cells (5 x 105 cells/0.1 ml) and 3,000-rad-irradi-
ated stimulator cells (104-106 cells/0.1 ml) were cocultured in a flat-bottomed microplate
(25860; Corning Glass Works, Corning, NY) in a humidified atmosphere containing 5%
COz at 37°C for 2, 3, 4, or 5 d, and were pulsed on each last day with f3H]thymidine
(1 gCi/well) followed by harvesting 12 h later.
Statistics.
￿
Group data in each experiment were compared with the analysis of variance
and then with student's t test when the data seemed to be parametric. However, when the
data seemed to be nonparametric, the Mann-Whitney U test was used; p = <0.05 was con-
sidered significant.
Results
Long-lasting Skin Allograft Tolerance in H-2Haplotype-identical Strain Combinations and
Specificity of Tolerance. As shown in Table 1, the recipient mice (C3H, H-2k, Mls-
1b; and BALB, H-2d, Mls-1b) were primed intravenously with 108 spleen cells of H-2
haplotype-identical donors (AKR, H-2k, Mls-1a; B10.BR, H-2k , Mls-1b; and DBA,
H-2d, Mls-1a) on day -2, and treated intraperitoneally with 200 mg/kg of CP on
day 0. Skin grafting with AKR, B10.BR, DBA, or B10.D2 was carried out on day
14. In all of the experiments, three control groups were set up as follows: group 1,
untreated (untreated controls); group 2, CP treatment alone (CP controls); and group
3, priming with donor spleen cells alone (primed controls).
In all of the combinations, a long-lasting skin allograft tolerance was produced
in the groups given both viable cells and CP (groups 4; Exp. 1-3) compared with
the other three control groups. In the tolerant groups, normal hair grew in the grafted
skin. In the CP control groups (groups 2) and the primed control groups (groups
3), however, the skin graft survival was not prolonged compared with the untreated
control groups (groups 1; Exp. 1-3).
When the C3H mice made tolerant of AKR were grafted with the third-party
skin (B10.BR), the skin graft survival was not prolonged compared with the CP con-
trol mice (group 5 vs. 6; Exp. 1). The same results were obtained when the C3H
mice made tolerant of BlO.BR were grafted with AKR skin (group 6; Exp. 2), and
when the BALB mice made tolerant of DBA were grafted with B10 .132 skin (group
6; Exp. 3).
Chimeric Analysis in C3HMice Made Tolerant ofAKR.
￿
As had been done with the
foregoing reports in other strain combinations (16), the existence ofmixed chimerism
in the C3H mice made tolerant of AKR with 108 AKR spleen cells plus CP was
examined (Table II).100
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In the C3H (Thy-1.2) mice made tolerant ofAKR (Thy-1.1), a small number of
Thy-1.1+ cells of donor (AKR) origin were detected in the recipient C3H lymph
node cells, but not in the thymus cells on day 14 (group 4-a). On day 35, Thy-1.1+
cells ofdonororigin were detected more clearly bothinthe thymus andin thelymph
nodes ofthe recipient C3H mice, and the proportion ofThy-1.2+ cells ofrecipient
origin decreased (group 4-b). Furthermore, on day 70, the proportion of Thy-1.1+
cells ofdonor origin reached 32.8% in the thymus (group 4-c). In the C3H mice
primed with AKR spleen cells alone, such mixed chimerism was not established
(group 3).
Similarly, in the BALB (Lyt-1.2) mice made tolerant of DBA (Lyt-1 .1), a small
number of Lyt-1.1* cells of donor (DBA) origin were also detected in the thymus
and lymph nodes of the recipients (BALB) as well (group 7).
In vitro Unresponsiveness ofSpleen Cellsfore C3H Mice Made Tolerant ofAKR.
￿
Two
segregating loci are found in the Mls trait. One locus on chromosome 1 is known
to stimulate the proliferation ofa high percentage ofT cells from the mice that are
identical in H-2 complex but differing at Mls loci. The locus has two alleles; Mls-la
and Mls-lb. Lymphocytes from the mice carrying Mls-la, such as AKR mice, are
a potent stimulator of T cells from the mice carrying Mls-lb, such as C3H mice.
On the other hand, lymphocytes from the mice carrying M18-1b are incapable of
stimulating T cells from the mice carrying Mls-la (24). There are some reports
(25-27), however, describing that Mls determinants cannot either act as transplan-
tation antigens or cause graft-vs.-host reactions. These results may implicate that
skin tolerance and Mls tolerance can be independent. To determine whether toler-
ance to Mls-1a was established in our CP-induced tolerance system, we have exam-
ined in vitro MLR ofspleen cells from the C3H mice that had been made tolerant
of AKR 5 wk earlier and had been carrying AKR skin for 3 wk.
As shown in Fig. 1, the spleen cells from the C3H mice made tolerant ofAKR
skinwere unresponsive in vitro toAKR stimulation, whereasthey normallyresponded
to the third-party BALB alloantigens. The spleen cells from the C3H mice treated
with CP alone (CP controls), however, responded normally to both the AKR and
third-party alloantigens in vitro. Thus, a specific tolerance to Mls-1a antigens was
confirmed in the C3H mice made tolerant of AKR skin.
Expression of TCR V,B6 in Tolerant Mice.
￿
Recently, several reports (4-7, 28) have
shown that the expression ofcertain TCR VS domains correlates with the reactivity
to Mls antigens. For example, T cell reactivity to Mls-1a antigens in vitro has been
shown to be strongly correlated with the expression ofTCR V06 (4). Thus, mature
T cells expressing TCRV06 are absent in Mls-1a strains ofmice, whereas these cells
constitute 10-15% of lymph node cells in Mls-1b strains of mice. In Mls-la mice,
the lack of V06+ cells is considered to be ascribed to the clonal deletion during
thymocyte maturation. Such V06-bearing receptors can be readily quantitated by
their specific reactivity with the mAb 44-22-1 (4).
To investigate the cellular basis of our CP-induced tolerance to Mls-la antigens,
we examined the expression ofTCR VS6 in the C3H (Mls-lb) mice that had been
made tolerant ofAKR (Mls-l a) and were carrying AKR skin, or in the BALB (Mls-
16) mice that had been made tolerant ofDBA (Mls-la) and were carrying DBA skin.
Thymocytes andlymphnode cells fromthe tolerant mice were stained with the anti-
V06 mAb 44-22-1. As consistent with an earlier report (29), only mature T cells ex-e
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Responder
￿
C3H (naive)
￿
C3H (tol . of AKR)
￿
C3H (CP control)
FIGURE 1.
￿
In vitro unresponsiveness ofspleen cells from C3Hmicemade tolerant ofAKRskin.
5 x 105 spleen cells from the naive C3H mice (naive), the C3H mice that hadbeen made tolerant
ofAKR5 wk earlier with AKRspleen cells plus CP andwere carrying AKRskin for 3 wk (tolerant
ofAKR), or the C3H mice that had received CP treatment alone (CP control), were incubated
with 104-106 3,000-rad-irradiated C3H (O), AKR ((:1), or BALB (A) spleen cells for 2, 3, 4,
or 5 d. Proliferation was represented by [3H]thymidine incorporation after the optimal 4-d in-
cubation.
pressing TCR V06 in the thymus were strongly stained with the mAb 44-22-1, while
immature thymocytes expressing V06 were stained in a low intensity. In some ex-
periments we used cortisone-resistant thymocytes (CRT), since theCRTwere reported
to represent a thymic subpopulation phenotypically and functionally equivalent to
mature T cells (21).
A representative immunofluorescence result was shown in Fig. 2, and all of the
data were summarized in Table III. An appreciable number of thymocytes in the
the naive C3H mice were strongly stained with the V06-specific mAb 44-22-1 (Fig.
2 A and Table III, group 1). In the C3H mice that had been made tolerant ofAKR
and were carrying AKR skin, the V06+ cells were not detected in the thymocytes
on day 35, as compared with those in the naive C3H mice (Fig. 2, A vs. E, Table
III, group 1 vs. 4-b), although the V06+ T cells remained at a normal level in the
thymocytes on day 14 (Table III, group 4-a). The same deletion was observed when
the CRT were examined (Table III, group 1 vs. 4-b). On the other hand, in the
lymph node cellsofthetolerantC3H mice on day 35, asmall but significant number
ofV06+ cells were detected, although the expression ofV06 was obviously decreased
as compared with that in the naive C3H mice (Fig. 2, Bvs. F, and Table III, group
1 vs. 4-b). The obvious decrease of V06+ T cells in the periphery was already ob-
served on day 14, whereas the number of those remained at a normal level in the
thymus (Table III, group 4-a). The number ofthe V06-bearing T cells further de-
creased in these mice on day 70 (Table III, group 4-c). In the C3H mice treated104
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with CP alone(Fig. 2, CandD, and Table III, group 2) andin theC3H miceprimed
withAKR spleen cells alone (Table III, group 3), the VS6-bearingT cells remained
at normal levels both in the thymus and in the lymph nodes. Furthermore, in the
C3H mice that had been made tolerant of B10.BR (Mls-lb) and were carrying
B10.BR skin, TCR V06 was normally expressed both in the thymus and in the
lymph nodes (Fig . 2, G and H, and Table III, group 5) .
Thymocytes
￿
Lymph node cells
￿
Mouse used
A
C
E
G
Relative fluorescence
(V~6)
12 .4%ID
0 .4%
Channel No .
￿
2p0
￿
UChau~l I s la.- ZpO
C311 (naive)
C311 (CP alone)
C311 (tol . of AKR)
C3R (to .l . of RIO .BR)
AKR (naive)
FIGURE 2.
￿
V06* T cells are deleted in thymocytes but no in lymph node cells ofC3H mice
made tolerant ofAKR. The thymocytes andlymph node cells were stained with themAb 44-22-1
(specific for TCR VA6), followed by fluoresceinated goat anti-rat Ig . Thin lines represent the
fluorescent conjugate alone. (A and B) Naive C3H mice ; (C and D) C3H mice givenCP treat-
ment alone; (E and F) C3H mice that had been made tolerant 5 wk earlier with AKR spleen
cells plus CP and were carryingAKR skin ; (G and H) C3H mice that had been made tolerant
5 wk earlier with B10.BR spleen cells plus CP and were carrying B10.BR skin ; and (I and,/)
naiveAKRmice . Data represent oneofthe five animals tested . All the other four showed similar
staining patterns in each panel .
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TABLE III
Expression of TCR V,B6 in Recipient Mice Made Tolerant ofMls-1° Antigens
' See first two footnotes of Table I.
1 The day of CP treatment is called day 0.
4 Mature T cells expressing TCR Vtr6 in the thymus are strongly stained with the mAb 44-22-1 .
II CRT were obtained 48 h after a single intraperitoneal injection of 4 mg hydrocortisone acetate.
p < 0.01 compared with groups 1 and 6.
" p < 0.01 compared with group 1 .
I1 Not significant compared with group 1 .
ss p < 0.01 compared with group 7 .
IIII p < 0.01 compared with groups 7 and 9.
In the BALB mice that had been made tolerant ofDBA and were carrying DBA
skin, thesame results were obtained asdescribed above in theC3Hmice made tolerant
ofAKR. In the thymocytes ofthe tolerant BALB mice, Mls-1a-reactive V#6-bearing
T cells were eliminated. In the lymph nodes, however, V#6+ cells were also clearly
detected despite the obvious decrease (Table III, group 8).
On the other hand, we also examined, as a control ofthe TCR VR6, the expres-
sion ofTCR V08 in the C3H mice that had been made tolerant ofAKR and were
carrying AKR skin. Thymocytes and lymphnode cells from the tolerant mice were
stained with the V,38-specific mAb KJ16-133 (23). As shown in Table IV, expres-
sion ofTCR V08 was only marginally reduced both in the thymus and in the pe-
riphery ofthe tolerant C3H mice, as compared with that in the naive C3H mice
(Table IV, group 1 vs. 4-a or 4-b).
Subset Analysis ofResidual V86+ Cells in the Lymph Nodes ofthe Tolerant Mice.
￿
As de-
scribed above, the tolerance to Mls-la antigens was established, as well as the skin
tolerance to AKR in the C3H mice given AKR spleen cells followed by CP (Fig.
1). In the lymph nodes ofthese tolerant C3H mice, however, V06
+ cells were clearly
detected despite theobviousdecrease (Fig. 2, F). Tofurtheranalyzethe lymph node
cells from the C3H mice made tolerant ofAKR 5 wk earlier, thesecells were stained
on day 35 with the V06-specific mAb 44-22-1 together with the mAb to CD4 orCD8
antigen for two-color flow cytometry.
As shown in Fig. 3, 8-9% ofthe lymph node cells in the normal C3H mice be-
longed to CD4+V#6+ subset, whereas 4-5% ofthose belonged to CD4-Vt36
+ subset.
Group
Recipient'
(treatment)
Timing: of
the assay
(on day X)
Percent V06
positive
t SD (n
Thymocytes
strongly
cells
= 5)
CRT11
Percent V06
positive cells
t SD (n = 5)
(Lymph node
cells)
1 C3H (naive) - 1 .7 t 0 .2 12.0 t 1 .1 11 .8 t 0.8
2 C3H (CP alone) 35 1 .9 t 0.3 ND 12.2 t 0.9
3 C3H (AKR-SC alone) 35 1 .8 t 0.3 ND 10.9 t 1.1
4-a C3H (AKR-SC + CP) 14 1 .5 t 0.3 ND 6.8 f 0.81
4-b 35 0.2 t 0.1** 0.5 t 0.3 5 .6 t 0.51
4-c 70 0.1 f 0.1** ND 3.1 t 0.71
5 C3H (1310.13R-SC + CP) 35 1 .6 t 0.211 ND 11 .6 t 0.611
6 AKR (naive) - 0.1 t 0.1 0.4 t 0.2 0.5 t 0.3
7 BALB (naive) - 1 .4 f 0.2 ND 11 .0 t 0.7
8 BALB (DBA-SC + CP) 35 0.1 t O.1ss ND 5.1 f 1 .21111
9 DBA (naive) - 0.0 t 0.1 ND 0.4 t 0.2106
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TABLE IV
Expression of TCR V,e8 in Recipient Mice Made Tolerant of Mls-l' Antigens
' See first two footnotes of Table I .
t The day of CP treatment is called day 0.
S Mature T cells expressing TCR V08 in the thymus are strongly stained with the mAb KJ16-133.
In the lymph nodes of the C3H mice made tolerant of Mls-la antigens, however,
CD4+ T cells using TCR VS6 were eliminated (<I%), whereas the percentage of
CD4-VS6+ T cells remained at a normal level (Fig. 3, A vs. B). The same results
were obtained when two-color analysis was done in the lymph nodes ofthe BALB
mice made tolerant ofDBA (Fig. 3, Cvs. D). Moreover, the same was thecasewhen
the assay wasdone onday 14usinglymphnode cellsfrom theC3Hmice madetolerant
of AKR 2 wk earlier (data not shown).
On the other hand, the percentage ofthe CD8+VS6+ T cells in the lymph nodes
of the C3H mice made tolerant of AKR was unchanged or marginally reduced as
compared with that in the naive C3H mice (Fig. 4, A vs. B). In turn, the CD8--
VS6+ T cells were hardly detected in the lymph nodes ofthe tolerant C3H mice (Fig.
4, A vs. B).
Furthermore, the lymph nodecells from thesame tolerant C3H mice were stained
with the V08-specific mAb KJ16-133 together with the mAb to CD4 antigen for two-
color flow cytometry. In the lymph nodes ofthe C3H mice made tolerant ofMls-l'
antigens, CD4+ Tcells using TCR Vsa were only marginally reduced as compared
with those in the naive C3H mice (Fig. 5, A vs. B). Such selective disappearance
as seen in the T cells using TCR VS6 was not observed in the T cells using TCR
VS8 in the C3H mice made tolerant of AKR.
Discussion
We have demonstarted here one ofthe mechanisms ofCP-induced skin allograft
tolerance in mice by examining the expression ofTCR VS6 that is exclusively used
for the T cells reactive against Mls-la-encoded antigens (4). At the relatively early
phase of mice rendered tolerant to Mls-la-encoded antigens, neither CD4+CD8-
nor CD4- CD8+ thymocytes bearing a high density of VS6 were detected in the
thymus ofthese mice in which mixed chimerism was observed (Fig. 2 E and Table
III, group 4-b). These results were considered to be Mls-la specific, since the ex-
pression of TCR VS6 was at a normal level in the thymus of the C3H mice (Mls-
16) made tolerant ofB10.BR (Mls-16) (Fig. 2), and since the expression ofTCR VS8
was only marginally reduced in the thymus ofC3H mice rendered tolerant to Mls-
la-encoded antigens (Table IV). This marginal reduction of the expression ofTCR
Group
Recipient'
(treatment)
Timingt of
the assay
(on day X)
Thymus (n = 5)
Percent V08 strongly positive
cells t SDS
Lymph node (n = 5)
(Percent V08 positive
cells t SD)
1 C3H (naive) - 2.5 t 0.3 18.9 t 1 .0
2 C3H (CP alone) 35 2.3 t 0.2 18.2 t 0.8
3 C3H (AKR-SC alone) 35 2.4 f 0.3 17.7 t 1 .1
4-a C3H (AKR-SC + CP) 35 2.0 f 0.3 16.5 t 0.7
4-b 70 1 .8 t 0.2 16.0 t 0.9
5 AKR (naive) - 1 .7 t 0.2 11 .2 t 0.7ETO ET AL .
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Figure 3 .
￿
CD4'VB6* T cells are selectively eliminated in lymph node cells of recipient mice
made tolerant ofthe Mls-1
a strain . Thelymphnode cells were double stained with PE-conjugated
anti-CD4 antibody andthe mAb44-22-1 (specific forTCRVo6) followed by FITC-conjugated
anti-rat IgG . The percentage of each positive population is given in the respective regions . (A)
Naive C3H mice ; (B) C3H mice that had been made tolerant 5 wk earlier with AKR spleen
cells plus CP and were carrying AKR skin ; (C) naive BALB mice ; (D) BALB mice that had
been made tolerant 5 wk earlier with DBA spleen cells plus CP and were carrying DBA skin .
Data represent one ofthe five animals tested . All the other four showed similar staining patterns
in each panel .
V#8 in the thymus may be ascribed to the deletion ofTCR VR8.t, as described by
Kappler et al . (5), which is also used for theT cells reactive to Mls-la-encoded an-
tigens . The apparent disappearance of V06 + T cells in the thymus was not due to
dilution of Vs6+ (CM)T cells by V06
- (AKR) T cells, since the proportion of Thy-
1.1 + cells of donor (AKR) origin was only small in the thymus of the recipientC3H
on day 35 (Table I1), and the elimination was also found in two-color flow cytometry
analysis of the thymocytes stained with mAb Thy-1 .2 together with the antiV06
mAb 44-22-1 (data not shown) . The elimination was more clearly shown when the
CRT were examined (Table III). Here, theCRT represent a thymic subpopulation
that are phenotypically and functionally equivalent to mature (CD4+ or CD8+ )T
cells (21) . Taken together, these data strongly suggest that the clonal elimination of
Mls-la-reactive V06+ cells in the thymus is actually occurring in theC3H mice made
tolerant ofAKR by the CP-induced tolerance method .
Another remarkable feature of the present study is the selective disappearance
ofCD4+VA6+ T cells in the periphery of the tolerant mice (Figs . 3 and 4), because
Qin et al . (15) reported that neither CD4+VS6+ nor CD8`V06' T cellswere deleted108
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FIGURE 4 .
￿
CD8'V06' T cells remain at normal levels in lymph node cells of recipient mice
made tolerant of the Mls-la strain. Thelymph node cells were double stained with PE-conjugated
anti-CD8 antibody andthe mAb 44-22-1 followed by FITC-conjugated anti-rat IgG . The per-
centage ofeach positive population is given in respective regions . (A) See Fig. 3 A; (B) see Fig.
3 B. Data represent one of the five animals tested . All the other four showed similar staining
patterns in each panel .
in the periphery of the adult mice that had been treated with themAb followed by
allogeneic BMT, and because MacDonald et al . (14) reported that both CD4'VS6'
and CD8+ VO6+ T cells were deleted in the periphery of the adult mice that had
been neonatally made tolerant to MIs-la-encoded antigens . The preferential disap-
pearance of CD4+VO6 + T cells in the present study was considered to be Mls-la
FIGURE 5 .
￿
CD4' Vgs' T cells are only marginally reduced in lymph node cells ofrecipientC3H
mice made tolerant of the Mls-la strain . The lymph node cells were double stained with PE-
conjugated anti-CD4 antibody and mAb KJ16-133 followed by FITC-conjugated anti-rat IgG .
The percentage of each positive population is given in respective regions. (A) See Fig. 3 A; (B)
see Fig. 3 B. Data represent one of the five animals tested . All the other four showed similar
staining patterns in each panel .ETO ET AL.
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specific (Figs. 3 and 5), and this state had been established before the intrathymic
clonal deletion occurred (Table 111). CD4+ Vo6+ T cells have been considered to be
mainly responsible for MLR to the Mls-la-encoded antigens (30, 31). At the induc-
tion phase of the CP-induced tolerance in the C3H mice, the Mls-la-reactive CD4+-
Vo6+ T cells proliferating after the AKR antigen stimulation may be totally abol-
ished by CP treatment (Fig. 3). In contrast, most of the CD8+ VO6+ T cells may
not be abolished with CP because of their resting cell cycle (17) and remain in the
periphery (Fig. 4), although a small number of the CD8+ T cells, whether or not
V,06+, which are responsible for AKR skin graft rejection, appear to be destroyed
by the AKR antigen stimulation plus CP, because such tolerant C3H mice were
always bearing AKR skin (Table I). Since there was no recruitment of Vo6+ ma-
ture T cells from the thymus to the peripheral lymph nodes in the recipient mice
rendered tolerant to Mls-la-encoded antigens, these residual CD8+ Vo6+ T cells ap-
peared to decrease gradually in number by day 70 after the CP treatment (Table
III, group 4-c).
A similar selective disappearance of Vs expression in CD4+ but not CD8+ T cells
in the periphery has previously been reported by Gao et al. (32) for T cells using
TCR VolI, which is reactive to I-E molecules. They reported that CD4+ Voii +, but
not CD8+Volt+, T cells were selectively deleted in the periphery of I-E+ mice, such
as (B6 x CBA/Ca)Fi mice. Although detail mechanisms of this selective deletion
of Vol i+ T cells in the I-E+ Fi mice have not been clarified, Gao et al. (32) explained
that the deletion appeared to occur during negative selection in the thymus. There-
fore, the mechanisms of the selective deletion reported by them are considered to
be quite different from those of thepresent system, becausethe selective destruction
of the CD4+VO6+ mature but not immature T cells is considered to be achieved
usually outside of the thymus in the present system by destructing the proliferating
T cells that are reactive against the tolerogenic antigens. The fact that VO6+ T cells
in theperiphery had obviouslydecreased on day 14 before the clonal deletion mech-
anisms started to work in the thymus (Table 111, group 4-a) may support this expla-
nation.
From their results showing that neither CD4+ VO6+ nor CD8+ Vo6+ T cells were
deleted in the periphery ofthe tolerant mice, Qin et al., (15) concludedthat the mech-
anisms of their antibody-induced tolerance to Mls-la-encoded antigens may be
clonal anergy but notclonal deletion. Although Qin et al. (15) did notshow thestatus
in the thymus in their study, it became clear from the present study that residual
Vo6+ T cells can exist in the periphery of the tolerant mice even if the clonal dele-
tion mechanism is working in the thymus. Some delay may be required to establish
acompletely Vo6+ cell-deleted state in the periphery of the adult tolerant mice. The
present result (Table III, group 4-c) indicating gradual decrease of the Vo6+ T cells
in the periphery in the chronic stage of tolerance may support this conclusion.
Moreover, the results obtained by MacDonald et a1. (14) in the neonatally induced
tolerance system may be, thus, compatible with our present results, because they
induced the tolerance in the neonatal stage and tested the Vo6+ T cells in the pe-
riphery of the adult mice.
As to the mechanism responsible for the intrathymic elimination of Mls-la-
reactive T cells, thymic chimerism seemed to be essential in CP-induced tolerance.
MacDonald et al. (31) have shown that dendritic cells and/or macrophages could11 0
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induce tolerance accompanied by the elimination of V06` cells in radiation bone
marrow chimeras. Another report stated that significant chimerism of bone
marrow-derived nonlymphoid cells wasdetected in the thymus ofneonatally tolerant
mice (33). Such chimerism may be important in the development and/or maintenance
of the tolerant state. As we have emphasized in the previous reports (16, 20), the
establishment of mixed chimerism in the thymus of the recipient mice made tolerant
of Mls-la strain with the donor spleen cells followed by CP was also confirmed in
the present study (Table II). The precise correlation between the duration of these
mixed chimerisms in the thymus and the intrathymic elimination of Mls-la-reactive
T cells using TCR V06+, however, has not been clear. In the present study using
the C3H mice made tolerant of AKR, neither mixed chimerism nor clonal deletion
of VR6
+ T cells was detected in the thymus on day 14 (Tables II and III). In the
tolerant C3H mice, however, intrathymic clonal deletion of VR6+ T cells was ob-
served on day 35, associating with mixed chimerism in the thymus (Tables II and
III). From our preliminary results, moreover, the duration of mixed chimerism ap-
pears to correlate with the maintenance of the intrathymic clonal deletion mecha-
nism in thechronic stage ofthe CP-induced tolerance(Eto et al., unpublisheddata).
These resultsstrongly suggest theclose correlation betweenthe intrathymic chimerism
and the clonal deletion mechanism.
From our previous (16-20) and present studies, the two major mechanisms that
are essential to our CP-induced tolerance system have been elucidated and clearly
segregated. The first mechanism is important to destroy specific mature T cells in
the periphery and may be called destruction ofanitgen-stimulated andthen prolifer-
atingcells. Namely, the reactive cells in the recipient mice are stimulated with injec-
tion ofallogeneic lymphoid cells. During thesubsequent cell proliferation, thesereactive
cells are specifically destroyed with CP, whereas nonreactive cells survive after the
CP treatment because of their resting cell cycle (17). The second mechanism is the
clonal deletion in the thymus as presented in this study. Although a further detailed
mechanism in deleting immature T cells in the thymus has not been made clear
yet (4, 5), the most important point is that the mechanism works in the thymus only
to delete immature (usually CD4 CD8 double-positive) T cells but not mature T
cells (29, 34).
The third majormechanism in ourCP-induced tolerance system may be genera-
tion of Ts cells (35), especially in the late stage of the tolerance. This aspect of the
CP-induced tolerancewas further analyzed by ourcolleagues (36). Although precise
relationships among these three major mechanisms of CP-induced tolerance have
not been made clear, all of them appear to be indispensable in inducing and main-
taining a long-lasting tolerance to skin allograft in mice.
Summary
When C3H (H-2k, MIs-1b) mice were primed intravenously with 10$ viable spleen
cells from AKR (H-2k, Mls-1a) and treated intraperitoneally with 200 mg/kg of cy-
clophosphamide (CP) 2 d later, not only a long-lasting skin allograft tolerance but
also a tolerance in mixed lymphocyte reaction to Mls-1a-encoded antigens was es-
tablished. The cellular mechanisms of CP-induced tolerance were examined by as-
sessing the V06-bearing T cells that are strongly correlated with reactivity to Mls-ETO ET AL.
￿
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la-encoded antigens bound to MHC class II molecules. At the relatively early stage
(2 or 5 wk) after the CP treatment, CD4+ Vs6' T cells of C3H origin were prefer-
entially eliminated in the lymph nodes of the tolerant mice, whereas CD8+V06'
T cells remained. On the other hand, neither CD4' CD8- nor CD4-CD8+ thymo-
cytes bearing a high density of V06 was detected in the chimeric thymus. Namely,
in the thymus of the tolerant C3H mice, neither mixed chimerism nor the clonal
deletion of the V06-bearing T cells was observed on day 14, whereas both of them
were observed on day 35. The clonal deletion and mixed chimerism in the thymus
were lasting for >10 wk after the CP treatment . Expression of V06 on the periph-
eral T cells in the tolerant C3H mice gradually reduced in the process oftime. These
results strongly suggested that the clonal deletion in the thymus was one of the essen-
tial mechanisms in the CP-induced tolerance system.
We thank Dr. H. Hengartner for generously providing the antiV06 mAb (clone 44-22-1 ,
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